Dividends Calendar Earnings Calendar
OCGN

OCGN | Ocugen Inc

Ocugen Inc
Category: Consumer goods
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Malvern, Pennsylvania, United States

Trade prices

  • Volume:
  • Market Cap: 1.77B
  • Prev closed:
  • Open: 8.94
  • High: 9.95
  • Low: 8.8
  • 52 week low: 0.28
  • 52 week high: 18.77
  • Dividends:No Dividends

Next ER: November 9, 2021  Before Market Opens



Top Stories (OCGN)

    Company Profile

    Ocugen, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing transformative therapies to treat rare and underserved eye diseases. Our breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug ? "one to many" and our novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema and diabetic retinopathy.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    April 1, 2022
    November 9, 2021-0.05 / -0.04- / -
    August 6, 2021-0.13 / -0.032- / -
    May 7, 2021-0.04 / 0.19- / 39.04M
    March 18, 2021-0.02 / -0.02- / -
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Nov 24, 2021 7.100 7.420
    7.420
    7.060
    8.67M -2.87%
    Nov 23, 2021 7.310 7.340
    7.550
    7.080
    11.91M -3.56%
    Nov 22, 2021 7.580 7.790
    7.905
    7.375
    11.54M -1.81%
    Nov 19, 2021 7.720 7.260
    8.110
    7.170
    22.24M 6.34%
    Nov 18, 2021 7.260 7.760
    7.900
    7.180
    14.09M -5.1%
    Nov 17, 2021 7.650 8.100
    8.150
    7.650
    12.84M -5.9%
    Nov 16, 2021 8.130 8.200
    8.310
    7.830
    15.15M -2.05%
    Nov 15, 2021 8.300 8.743
    8.773
    8.270
    11.72M -5.9%
    Nov 12, 2021 8.820 8.670
    8.860
    8.360
    12.91M 1.50%
    Nov 11, 2021 8.690 8.515
    8.980
    8.030
    29.11M 1.88%
    view more
    NASDAQ - Nasdaq Stock Market

    News

    News for (OCGN)

    This company doesn't provide a dividend.

    Key Persons

    • CEO :  Shankar Musunuri (Sep 2019–)
    • CFO :  Shankar Musunuri

    Talk about Ocugen Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Nov 9, 2021 (Same day)

    hain syy ash jazz cah dar dhi wynn meg acb nio xec 


    Jump to (Finance sites)

    Their Official Profiles 

    TwitterLinkedInInstagramYoutube

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Technical Analysis For Dummies
    Buy on Amazon

    Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.

    A simple, straightforward guide to the fundamentals of technical analysis